Chengming Fan1, Vladimir G Fast2, Yawen Tang2, Meng Zhao2, James F Turner2, Prasanna Krishnamurthy2, Jack M Rogers2, Mani T Valarmathi2, Jinfu Yang3, Wuqiang Zhu4, Jianyi Zhang5. 1. Department of Biomedical Engineering, School of Medicine, School of Engineering, University of Alabama at Birmingham, USA; Department of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Changsha, China. 2. Department of Biomedical Engineering, School of Medicine, School of Engineering, University of Alabama at Birmingham, USA. 3. Department of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Changsha, China. 4. Department of Biomedical Engineering, School of Medicine, School of Engineering, University of Alabama at Birmingham, USA. Electronic address: wzhu@uab.edu. 5. Department of Biomedical Engineering, School of Medicine, School of Engineering, University of Alabama at Birmingham, USA. Electronic address: jayzhang@uab.edu.
Abstract
BACKGROUND: Cardiomyocytes that have been differentiated from CCND2-overexpressing human induced-pluripotent stem cells (hiPSC-CCND2OE CMs) can proliferate when transplanted into mouse hearts after myocardial infarction (MI). However, it is unknown whether remuscularization can replace the thin LV scar and if the large muscle graft can electrophysiologically synchronize to the recipient myocardium. Our objectives are to evaluate the structural and functional potential of hiPSC-CCND2OE CMs in replacing the LV thin scar. METHODS: NOD/SCID mice were treated with hiPSC-CCND2OE CMs (i.e., the CCND2OE group), hiPSC-CCND2WT CMs (the CCND2WT group), or an equal volume of PBS immediately after experimentally-induced myocardial infarction. The treatments were administered to one site in the infarcted zone (IZ), two sites in the border zone (BZ), and a fourth group of animals underwent Sham surgery. RESULTS: Six months later, engrafted cells occupied >50% of the scarred region in CCND2OE animals, and exceeded the number of engrafted cells in CCND2WT animals by ~8-fold. Engrafted cells were also more common in the IZ than in the BZ for both cell-treatment groups. Measurements of cardiac function, infarct size, wall thickness, and cardiomyocyte hypertrophy were significantly improved in CCND2OE animals compared to animals from the CCND2WT or PBS-treatment groups. Measurements in the CCND2WT and PBS groups were similar, and markers for cell cycle activation and proliferation were significantly higher in hiPSC-CCND2OE CMs than in hiPSC-CCND2WT CMs. Optical mapping of action potential propagation indicated that the engrafted hiPSC-CCND2OE CMs were electrically coupled to each other and to the cells of the native myocardium. No evidence of tumor formation was observed in any animals. CONCLUSIONS: Six months after the transplantation, CCND2-overexpressing hiPSC-CMs proliferated and replaced >50% of the myocardial scar tissue. The large graft hiPSC-CCND2OE CMs also electrically integrated with the host myocardium, which was accompanied by a significant improvement in LV function.
BACKGROUND: Cardiomyocytes that have been differentiated from CCND2-overexpressing human induced-pluripotent stem cells (hiPSC-CCND2OE CMs) can proliferate when transplanted into mouse hearts after myocardial infarction (MI). However, it is unknown whether remuscularization can replace the thin LV scar and if the large muscle graft can electrophysiologically synchronize to the recipient myocardium. Our objectives are to evaluate the structural and functional potential of hiPSC-CCND2OE CMs in replacing the LV thin scar. METHODS: NOD/SCID mice were treated with hiPSC-CCND2OE CMs (i.e., the CCND2OE group), hiPSC-CCND2WT CMs (the CCND2WT group), or an equal volume of PBS immediately after experimentally-induced myocardial infarction. The treatments were administered to one site in the infarcted zone (IZ), two sites in the border zone (BZ), and a fourth group of animals underwent Sham surgery. RESULTS: Six months later, engrafted cells occupied >50% of the scarred region in CCND2OE animals, and exceeded the number of engrafted cells in CCND2WT animals by ~8-fold. Engrafted cells were also more common in the IZ than in the BZ for both cell-treatment groups. Measurements of cardiac function, infarct size, wall thickness, and cardiomyocyte hypertrophy were significantly improved in CCND2OE animals compared to animals from the CCND2WT or PBS-treatment groups. Measurements in the CCND2WT and PBS groups were similar, and markers for cell cycle activation and proliferation were significantly higher in hiPSC-CCND2OE CMs than in hiPSC-CCND2WT CMs. Optical mapping of action potential propagation indicated that the engrafted hiPSC-CCND2OE CMs were electrically coupled to each other and to the cells of the native myocardium. No evidence of tumor formation was observed in any animals. CONCLUSIONS: Six months after the transplantation, CCND2-overexpressing hiPSC-CMs proliferated and replaced >50% of the myocardial scar tissue. The large graft hiPSC-CCND2OE CMs also electrically integrated with the host myocardium, which was accompanied by a significant improvement in LV function.
Authors: Karl Toischer; Wuqiang Zhu; Mark Hünlich; Belal A Mohamed; Sara Khadjeh; Sean P Reuter; Katrin Schäfer; Deepak Ramanujam; Stefan Engelhardt; Loren J Field; Gerd Hasenfuss Journal: J Clin Invest Date: 2017-10-30 Impact factor: 14.808
Authors: Jianhua Zhang; Gisela F Wilson; Andrew G Soerens; Chad H Koonce; Junying Yu; Sean P Palecek; James A Thomson; Timothy J Kamp Journal: Circ Res Date: 2009-02-12 Impact factor: 17.367
Authors: Wilhelm Roell; Thorsten Lewalter; Philipp Sasse; Yvonne N Tallini; Bum-Rak Choi; Martin Breitbach; Robert Doran; Ulrich M Becher; Seong-Min Hwang; Toktam Bostani; Julia von Maltzahn; Andreas Hofmann; Shaun Reining; Britta Eiberger; Bethann Gabris; Alexander Pfeifer; Armin Welz; Klaus Willecke; Guy Salama; Jan W Schrickel; Michael I Kotlikoff; Bernd K Fleischmann Journal: Nature Date: 2007-12-06 Impact factor: 49.962
Authors: Drew M Titmarsh; Nick R Glass; Richard J Mills; Alejandro Hidalgo; Ernst J Wolvetang; Enzo R Porrello; James E Hudson; Justin J Cooper-White Journal: Sci Rep Date: 2016-04-21 Impact factor: 4.379
Authors: Eva Querdel; Marina Reinsch; Liesa Castro; Thomas Eschenhagen; Florian Weinberger; Deniz Köse; Andrea Bähr; Svenja Reich; Birgit Geertz; Bärbel Ulmer; Mirja Schulze; Marc D Lemoine; Tobias Krause; Marta Lemme; Jascha Sani; Aya Shibamiya; Tim Stüdemann; Maria Köhne; Constantin von Bibra; Nadja Hornaschewitz; Simon Pecha; Yusuf Nejahsie; Ingra Mannhardt; Torsten Christ; Hermann Reichenspurner; Arne Hansen; Nikolai Klymiuk; M Krane; C Kupatt Journal: Circulation Date: 2021-03-02 Impact factor: 29.690